IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260950. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $520,498 | -47.7% | 64,900 | -3.4% | 0.00% | – |
Q1 2024 | $995,904 | -22.6% | 67,200 | -57.5% | 0.00% | – |
Q4 2023 | $1,286,979 | -60.9% | 158,300 | -78.1% | 0.00% | -100.0% |
Q3 2023 | $3,289,195 | +622.1% | 722,900 | +1017.3% | 0.00% | – |
Q2 2023 | $455,488 | +79.6% | 64,700 | +55.9% | 0.00% | – |
Q1 2023 | $253,565 | +35.9% | 41,500 | +42.1% | 0.00% | – |
Q4 2022 | $186,588 | -61.6% | 29,200 | -42.4% | 0.00% | – |
Q3 2022 | $486,000 | -92.3% | 50,700 | -91.1% | 0.00% | -100.0% |
Q2 2022 | $6,305,000 | – | 571,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANE STREET GROUP, LLC | 571,100 | $6,305,000 | 0.00% |
SIMPLEX TRADING, LLC | 36,000 | $397,000 | 0.00% |
GROUP ONE TRADING, L.P. | 10,100 | $112,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |